NOM Nuveen latest quarterly earnings report carries no consensus comparable metrics as management reaffirms its muni portfolio strategy Moderna Inc MRNA Counterparty Arbutus Biopharma Secures Regulatory Catalyst Amid Settled LNP Licensing Agreement PSTG Everpure enterprise AI storage sales show steady momentum as key client contract wins lift longterm outlook Is Georgia GPJA stock under speculative pressure